A Retrospective Analysis of Antithrombin III Replacement Therapy for the Treatment of Hepatic Sinusoidal Obstruction Syndrome in Children Following Hematopoietic Stem Cell Transplantation

被引:2
作者
Kim, Miriam [1 ]
Rao, Seema [1 ,3 ]
Eickhoff, Jens C. [2 ]
DeSantes, Kenneth B. [1 ]
Capitini, Christian M. [1 ]
机构
[1] Univ Wisconsin, Dept Pediat, Carbone Canc Ctr, Sch Med & Publ Hlth, Madison, WI USA
[2] Univ Wisconsin, Dept Biostat & Med Informat, Carbone Canc Ctr, Sch Med & Publ Hlth, Madison, WI USA
[3] Baylor Coll Med, Dept Pediat, Texas Childrens Canc & Hematol Ctr, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
venoocclusive disease; BMT; stem cell transplantation; sinusoidal obstruction syndrome; antithrombin III; BONE-MARROW-TRANSPLANTATION; VENOOCCLUSIVE DISEASE; PREVENTION; TRIAL; LIVER;
D O I
10.1097/MPH.0000000000001422
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatic sinusoidal obstruction syndrome (SOS) remains a serious complication of hematopoietic stem cell transplantation (HSCT). In this single institution retrospective case series, 18 children developed SOS after HSCT. Patients were treated with antithrombin III (ATIII), defibrotide, or ATIII followed by defibrotide. Twelve of 13 patients who were treated with ATIII therapy alone had complete resolution of SOS, including 4 of 5 children with severe SOS. In this limited cohort, ATIII was safe and successfully prevented progression of hepatic SOS following HSCT in the majority of children at our center.
引用
收藏
页码:145 / 148
页数:4
相关论文
共 50 条
[41]   Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes [J].
Yakushijin, K. ;
Atsuta, Y. ;
Doki, N. ;
Yokota, A. ;
Kanamori, H. ;
Miyamoto, T. ;
Ohwada, C. ;
Miyamura, K. ;
Nawa, Y. ;
Kurokawa, M. ;
Mizuno, I. ;
Mori, T. ;
Onizuka, M. ;
Taguchi, J. ;
Ichinohe, T. ;
Yabe, H. ;
Morishima, Y. ;
Kato, K. ;
Suzuki, R. ;
Fukuda, T. .
BONE MARROW TRANSPLANTATION, 2016, 51 (03) :403-409
[42]   Retrospective analysis of veno-occlusive disease/sinusoidal obstruction syndrome in paediatric patients undergoing hematopoietic cell transplantation-a multicentre study [J].
Ragoonanan, Dristhi ;
Abdel-Azim, Hisham ;
Sharma, Aditya ;
Bhar, Saleh ;
Mcarthur, Jennifer ;
Madden, Renee ;
Rahrig, April ;
Bajwa, Rajinder ;
Wang, Jian ;
Sun, Victoria ;
Wright, Mariah ;
Lassiter, Rebekah ;
Shoberu, Basirat ;
Kawedia, Jitesh ;
Khazal, Sajad Jawad ;
Mahadeo, Kris Michael .
LANCET REGIONAL HEALTH-AMERICAS, 2024, 33
[43]   Successful Treatment of Sinusoidal Obstructive Syndrome with Deceased-Donor Liver Transplant Following Hematopoietic Stem Cell Transplant [J].
Yu, Young-Dong ;
Kim, Dong-Sik ;
Yoon, Young-In ;
Park, Yong .
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2021, 19 (08) :880-883
[44]   Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day+100 survival following haematopoietic stem cell transplantation [J].
Richardson, Paul G. ;
Smith, Angela R. ;
Triplett, Brandon M. ;
Kernan, Nancy A. ;
Grupp, Stephan A. ;
Antin, Joseph H. ;
Lehmann, Leslie ;
Miloslavsky, Maja ;
Hume, Robin ;
Hannah, Alison L. ;
Nejadnik, Bijan ;
Soiffer, Robert J. .
BRITISH JOURNAL OF HAEMATOLOGY, 2017, 178 (01) :112-118
[45]   BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation [J].
Dignan, Fiona L. ;
Wynn, Robert F. ;
Hadzic, Nedim ;
Karani, John ;
Quaglia, Alberto ;
Pagliuca, Antonio ;
Veys, Paul ;
Potter, Michael N. .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (04) :444-457
[46]   Busulfan conditioning and prognostic impact of jaundice in late-onset sinusoidal obstruction syndrome following allogeneic hematopoietic cell transplantation [J].
Takagi, Shinsuke ;
Watanabe, Otoya ;
Yamaguchi, Kyosuke ;
Kageyama, Kosei ;
Kaji, Daisuke ;
Taya, Yuki ;
Nishida, Aya ;
Ishiwata, Kazuya ;
Yamamoto, Hisashi ;
Asano-Mori, Yuki ;
Yamamoto, Go ;
Wake, Atsushi ;
Taniguchi, Shuichi ;
Uchida, Naoyuki .
BONE MARROW TRANSPLANTATION, 2024, :418-421
[47]   Nationwide Survey of Defbrotide and Recombinant Human Soluble Thrombomodulin for Treatment of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation [J].
Yakushijin, K. ;
Ikezoe, T. ;
Ohwada, C. ;
Kudo, K. ;
Okamura, H. ;
Goto, H. ;
Yabe, H. ;
Yasumoto, A. ;
Kuwabara, H. ;
Fujii, S. ;
Kagawa, K. ;
Ikebe, T. ;
Onishi, Y. ;
Morishita, Y. ;
Watamoto, K. ;
Uoshima, N. ;
Nakamura, D. ;
Ota, S. ;
Ueda, Y. ;
Oyake, T. ;
Koike, K. ;
Mizuno, I. ;
Iida, H. ;
Katayama, Y. ;
Hiroatsu, A. ;
Kato, K. ;
Okamura, A. ;
Kikuta, A. ;
Fukuda, T. .
BONE MARROW TRANSPLANTATION, 2016, 51 :S77-S78
[48]   Sinusoidal Obstruction Syndrome of the Liver after Hematopoietic Stem Cell Transplantation: Decision Making for Orthotopic Liver Transplantation [J].
Christian Koenecke ;
Moritz Kleine ;
Harald Schrem ;
Utz Krug ;
Bjoern Nashan ;
Michael Neipp ;
Arnold Ganser ;
Bernd Hertenstein ;
Juergen Klempnauer .
International Journal of Hematology, 2006, 83 :271-274
[49]   Sinusoidal obstruction syndrome of the liver after hematopoietic stem cell transplantation: Decision making for orthotopic liver transplantation [J].
Koenecke, C ;
Kleine, M ;
Schrem, H ;
Krug, U ;
Nashan, K ;
Neipp, M ;
Ganser, A ;
Hertenstein, B ;
Klempnauer, J .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 83 (03) :271-274
[50]   Hepatic veno-occlusive disease following hematopoietic stem cell transplantation [J].
Richardson, P ;
Guinan, E .
ACTA HAEMATOLOGICA, 2001, 106 (1-2) :57-68